Agmon with Tulchinsky Law Firm's diverse offering serves a varied client base of venture capital funds looking to invest in start-ups within the sector, in addition to handling data protection and privacy issues. Ehud Arad, Osnat Sarusi Firstater, and Uri Barak co-lead the practice. Arad’s primary areas of focus include multijurisdictional transactions, having acted for a large number of healthcare start-ups; Firstater leads the firm’s technology practice, primarily advising medtech start-ups on joint ventures and M&A; and Barak is known for his extensive commercial experience, having handled a broad range of series financings and management buyouts. Alon Tabak-Aviram is known for assisting biotech and pharma companies on the negotiation of R&D and manufacturing agreements.

Legal 500 Editorial commentary

Testimonials

Collated independently by Legal 500 research team.

  • ‘This is the team I turn to for any work in Israel. Responsive, competent, experienced and good commercial sense.’

  • ‘They have very significant accumulated experience in the healthcare fields, including, but not limited to, licensing, employment law, IP, cyber security and privacy, procurement, investments and other financing and everything else needed by a young and growing company.’

  • ‘Yifat Tsafrir is a great pleasure to work with; she is pleasant, professional and always helps in getting the deal done.’

Key clients

  • Clalit Healthcare
  • Livnat Poran
  • Nuversys
  • Past and current directors of Teva Pharmaceutical Industries Ltd.
  • Shaare Zedek Scientific Ltd.
  • Cantor Fitzgerald
  • T- Syte
  • Virtual Care
  • Hospitech Respiration Ltd.
  • Lifebiotic Medical research Ltd.
  • Phebra Pty Ltd
  • Kaizen Bio-Tech
  • Enzysurge
  • Reuth Rehabilitation Hospital
  • Teva Pharmaceutical Industries Ltd.
  • Minovia
  • Neuroderm
  • The National Institute for Biotechnology in the Negev
  • Ziv Health care
  • CH-Health
  • RedHill Biopharma Ltd.
  • ConTIPI Medical Ltd.
  • Luneau Technology
  • Haldor
  • Biond Biologics
  • RA Capital
  • Widex

Work highlights

  • Acting for The National Institute for Biotechnology in the Negev, LTD., a research institute located within Ben-Gurion University, in their licensing, joint ventures, and collaboration activities in Israel and abroad, including with companies in the U.S., Japan, and additional jurisdictions.
  • Representing Teva's Directors in a motion to certify a derivative action submitted against Teva, it's officers and a consulting company. The motion concerns the purchase of the Mexican drug company named Rimsa.
  • Advising Betalin, a medical start-up developing an innovative therapy for diabetes treatment that aims to replace insulin therapy for patients, on a Master License Agreement with Yissum Research Development Company, as well as various trial and cooperation agreements with medical institutes internationally, and an investment transaction.

Practice head

The lawyer(s) leading their teams.

Ehud Arad, Osnat Sarusi Firstater, Uri Barak

Other key lawyers

Alon Tabak-Aviram, Gershon Shalom-Winter, Tamar Nesher, Osnat Sarusi-Firstater, Yifat Tsafrir